Alcon Names Stephen S. Lane, MD, as Chief Medical Officer

May 12, 2017: By Joan McKenna
Stephen Lane, MD

Stephen Lane, MD

Ophthalmologist Stephen S. Lane, MD, will join Alcon as chief medical officer and global head of clinical strategy, as of June 1, the company announced May 8.

Lane specializes in cataract surgery, cornea/external diseases, anterior segment surgery, LASIK, and refractive surgery.

He is a founding partner of Associated Eye Care of Stillwater, Minnesota, and was president of the American Society of Cataract and Refractive Surgery (ASCRS) from 2003 to 2004.

Alcon, the Fort Worth, Texas-based eye care division of Switzerland’s Novartis, said Lane’s experience in ophthalmic surgery, contact lens and intraocular lens development, clinical trial design and execution, and the regulatory process should complement Alcon’s strategy.

Lane succeeds Peter Richardson, MD, in the role.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

FDA Ophthalmic Devices Panel to hold Meeting Oct. 27

Novartis’ RTH258 Successful in Two Phase III Studies for nAMD

Ocugen Closes $7.5 Million Series B Round

Genentech Uses Vital Art and Science Vision-Testing App in Phase II Study of Sustained Delivery of Lucentis

US Supreme Court Ruling Shortens Time to Market for Biosimilars

Ellex Acquires Royalty Commitment for iTrack Device for $2.15 Million

Johnson & Johnson Vision Names Jonathan Talamo, MD, Chief Medical Officer

Teva Launches Generic Versions of Pataday in US

David Karcher Stepping Down as Executive Director, CEO of ASCRS

EyeGate Raises $10 Million in Public Offering

Aerie Raises $125 Million through Upsized Public Offering, ATM Program

pSivida’s Durasert for Posterior Segment Uveitis Successful in Second Phase III Study

Mynosys Zepto Receives US FDA 510(k) Clearance

Ozurdex, Humira Gain NICE Backing for Non-infectious Posterior Uveitis

Roger Steinert, Pioneer in Ophthalmology, Dies at 66

Carl Zeiss Meditec to Build New Innovation Center in Northern California

Gottlieb Says FDA to Publish List of Drugs Without Generic Competition

REGENXBIO Announces Phase I Clinical Trial for RGX-314 Gene Therapy for Wet AMD

Belkin Laser Closes Nearly $5 Million Financing Round

Valeant in Talks to Sell Surgical Business to Carl Zeiss Meditec

Coming soon

2017 Cataract Surgical Equipment: A Global Market Analysis for 2016 to 2022